Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05194852Completed
Randomised, open-label trial of ropivacaine in adhesive capsulitis of shoulder (AC), sponsored by Tanta University. Primary endpoints: Visual Analogue Scale at 3 months and Shoulder Pain and Disability Index at 3 months. Started Jan 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05194852.